" v u' H9 Y1 i6 `" L0 @ N1 ` k# y: C$ x3 d7 e/ I K
! s6 v+ u2 g- Z \/ e+ _$ t( ~( z & l! P3 n' j/ h: Q8 @: S - y q* g( g: |) M8 O: i5 a5 \" a l8 R3 U; @$ g5 ~; n
" C9 j3 I( l, V, i* ?+ Q
4 I* U1 m# m* F6 _" M# e+ |) a& V# g8 h; [
3 p" l3 M6 h' k k# r2 {3 D2 D/ X+ ~. ^2 T B- E/ C( H/ K
5 B$ R/ V0 k/ x4 p+ G9 F
- d) C, {" b7 X Q4 Y4 Y2 P$ n
& i9 Y2 o! I( O6 W5 a l1 e: q: Y% J1 U5 E4 o& j2 ~; n. ~
3 {) [: n2 L5 \) X2 S5 [7 B' c
0 O# R8 C: A3 K) h* p3 D8 R9 b' D
1 f; N: G: v0 S. ?& F4 j& v
, H" E7 w' C, e7 j/ d
7 Q7 R$ d2 m$ H0 O- t! |: S+ b3 I. L1 ~+ W, H! g4 l
. z; ]* e! O$ a4 {
$ Z, c( Q7 f, U
Tentative Session 3 o9 y9 n/ G9 ?China Classification and Variable Selection 3 A. \5 a6 g. |: {# Q
(Chair: Yang Li, Renmin University of China)% C M( R) ]4 p k# F5 w# W& ]# \
Clinical information data mining and application X' s1 t8 s/ J4 I s
(Chair: Xiuhua Guo, Capital Medical University)0 O u7 I0 s) f. m: S! c
Japan Missing Data in Clinical Trials: Basic Concepts and Practical Issues in Japan, b6 V9 o) H- w. U; E
(Chair: Hideki Suganami, Ph.D. Kowa Co., Ltd., Satoru Fukinbara, Ph.D. Ono Pharmaceutical Co., Ltd.)5 m; J9 m" g; `' J
1 ]/ A& O$ E5 N/ \* m6 K( c
Design and conduct of clinical trials for preventing missing data * X8 n- _& J4 G8 X(Speaker: Shiro Tanaka, Ph.D.Kyoto University) 2 Z- w& o" p! [! V* V) [( \ Some examples of the treatment of missing data in investigator-initiated clinical trials, ~, Y9 y D$ ^3 {4 l, U
(Speaker: Yoichi M. Ito, Ph.D.Hokkaido University)+ x5 P* B+ D+ p; o) k
Actual practice of handling of missing data in clinical trials 6 n, n. ?$ l/ A1 u% j2 R/ d/ u(Speaker: Nobushige Matsuoka, Ph.D., Yoichi Ii, Ph.D., Tamotsu Yoshiyama, M.S., Norisuke Kawai, Ph.D. ,Clinical Statistics, Pfizer Japan Inc.) 1 v# Y0 n: Z' o$ D# L; E) A Survey results from JPMA member companies: Current approach for missing data in pivotal registration trials ! t- s4 t2 u6 c# d: l" N(Speaker: Satoru Tsuchiya, M.S. ,Biostatistics group, Data science Dainippon Sumitomo Pharma, Co., Ltd.)9 E0 O9 Z5 N( {, \/ o
" ]' I; [) O+ T* k! l
, X' `% ?& U8 O# @8 t
9 P6 n! J: P1 H$ e6 S2 r * \ D# s- R2 gKorea 9 b: q4 I1 K1 b" S8 S! }! q1 A3 q3 e! F
) u- z5 V% e- u) K; [8 m/ s O
8 z H$ N$ ^. Y; z- y
; _. Z; t) `/ `: b" x! D1 B$ f5 `& E7 A3 k' v
2 I, Z0 C8 F) t5 L
Korea Selected Topics in Biometrics study$ e* i4 ` K' e" c$ v
(Chair:Hyonggin An, Korea University)% k3 B- B# z. w5 l
Identification of Variant Associated with Disease using Protein Structural Feature-based Prioritization* m; `9 t+ L/ ^4 {+ _+ u& B- T
(Speaker: Tae-Rim Lee,Korea National Open University,Min-Seok Kwon(Seoul National University),Sungho Won(Chung Ang University),Taesung Park(Seoul National University)) + p8 A5 z/ ?6 M5 F% _) a. P/ ~. y; Y 4 a, F3 f" }/ R& m3 s) Y
Differential Expression Detection in RNA-seq Data with a Small Number of Replicates6 N4 A6 Q2 x9 X/ E
(Speaker: Jungsoo Gim(Seoul National University), Taesung Park(Seoul National University)) S4 b) s" `. H# w. Y/ o! ] Investigation of Relationship between Influenza Occurrence and Climatic Factors in Three Major Regions in Korea using Time Series Analysis / x5 }% L5 t$ I. Q S3 t) S( h: j(Speaker: Hyonggin An (Korea University College of Medicine)and Sang-A Cho (National Cancer Center in Korea)): V z7 n& j" e$ p. z* M
Chair: Jinheum Kim, University of Suwon ! w1 r0 \0 v) F* s- s+ [ Additive Hazard Model with Additive Frailty for Semi-Competing Risks Data (Speaker: Yun-Nam Kim (Severance Hospital Clinical Trials Center), Chung Mo Nam(Yonsei University College of Medicine), Yang-Jin Kim(Sookkmyung Women’s University), and Jinheum Kim(University of Suwon)) + A& ^9 C7 |3 c8 J& E* p6 p3 q Variable Selection in Competing-Risks Frailty Models using Penalized H-likelihood- Y$ L+ g9 d u8 ^
(Speaker: Do Ha (Daegu Haany University) and Youngjo Lee (Seoul National University)) ( k5 P5 k* C; Y) w Gene-Gene Interaction Analysis with Survival Phenotype 6 h$ }9 I/ V5 }/ z& B# B, s/ `7 n (Speaker: Seungyeon Lee (Sejong University), Jin-SeokOh(Sejong University), Min-Seok Kwon(Seoul National University), and Taesung Park(Seoul National University)) ; f# a4 O6 O4 D4 S! R l Maximally Selected Two-sample Gray Statistics with Competing Risks Data 7 J* N( A! \ {9 W/ J9 X" `' ](Speaker: Jinheum Kim (University of Suwon), Sook-young Woo(Samsung Advanced Institute of Technology), Seonwoo Kim(Samsung Advanced Institute of Technology)) 3 Y5 `4 H) f3 V) S% ?; \Singapore Session title: Likelihood based inference for complex models1 k! D8 e2 E- ?! d) v& E
A multiple imputation method for longitudinal data with covariate measurement error under generalized partially linear mixed models + u; z. ]4 z4 q, `( q: h(Speaker: Xiang Liming(Nanyang Technological University))0 j$ t; f: [5 [ e' Y7 Q6 k# W
Bayesian Empirical Likelihood - ~2 h9 b4 \3 K( o(Speaker: Sanjay Chaudhuri(National University of Singapore, Singapore))% I+ f0 _; r( c% @8 S. O9 Q* f( J
Consistent Cross-Validation for Tuning Parameter Selection in High-Dimensional Variable Selection0 b! g1 v& L% A$ I; y" ~; I- O8 V% T
(Speaker: Yang Feng(Columbia University))% m; L) ~5 m7 k: c. ?
A sign based loss approach to model selection in nonparametric regression9 R, o) V4 ]2 ?
(Speaker: Li Jialiang (National University of Singapore, Singapore))2 S3 z! g2 x$ L% `& F
Thailand Meta analysis in Clinical Trials2 O' V' r: e. h& s' \
Publication Bias and Sensitivity Analysis for Meta-Analysis of Multi-Arm Trials. ]. `7 m9 _* p8 x8 Y. X
(Speaker: Dr. Hathaikan Chootrakool (Suan Dusit Rajabhat University)) , N8 O& p$ m. h Some New Tests for Homogeneity of Relative Risks in Meta-Analysis" A, O8 G% O8 C# i
(Speaker: Assoc. Prof. Dr. Chtwongkasemukiat Viwatwongkasem (Mahidol University)). e/ O% Z. K4 L% ?2 }5 R0 M
Application of Network Meta-analysis in Randomized Controlled Trials8 C' U% q8 t5 `+ | d. `6 y; R
(Speaker: Dr. Ammarin Thakkinstian(Ramathibodi Hospital, Mahidol University)) 1 l. F! W/ ]1 f% _* I" S- e - S1 y, I' k4 d+ x - c# q, l2 @8 K. T' G0 J ) a4 |2 W7 b6 `" w5 E5 N5 T6 p: [1 K0 `4 a
9 E9 \8 }& O6 m1 W5 h$ f
2 F8 j6 S3 B# [1 s) w: O5 j9 t